triazoles has been researched along with amsacrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gueorguieva, M; Schloffer, D; Skladanowski, A; Uhl, M; Wesierska-Gadek, J | 1 |
| Berthou, C; Eveillard, JR; Ianoto, JC; Karam, A; Le Flohic, AM; Le Roy, JP; Misery, L; Quinio, D | 1 |
2 other study(ies) available for triazoles and amsacrine
| Article | Year |
|---|---|
Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout cells to antitumor triazoloacridone C-1305 is associated with permanent G2 cell cycle arrest.
Topics: Acridines; Amsacrine; Animals; Apoptosis; CDC2 Protein Kinase; Cell Division; Cyclin B; DNA Damage; Fibroblasts; G2 Phase; Mice; Mice, Knockout; Poly(ADP-ribose) Polymerases; Topoisomerase II Inhibitors; Triazoles; Tumor Suppressor Protein p53 | 2004 |
[Disseminated cutaneous and visceral fusariosis in an aplastic patient: an unusual digestive entry].
Topics: Adult; Amsacrine; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diet; Fusarium; Humans; Immunocompromised Host; Male; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Triazoles; Voriconazole | 2005 |